Iovance Biotherapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2008 | — | — | $2.9K |
| Dec 2009 | — | — | $8.3K |
| Jun 2010 | — | — | $209.3K |
| Sep 2010 | — | — | $795.9K |
| Dec 2010 | $822.9K | $1.5M | $1.3M |
| Mar 2011 | — | — | $723.0K |
| Jun 2011 | $1.9M | $466.2K | $268.6K |
| Sep 2011 | $9.1M | $3.4M | $128.4K |
| Dec 2011 | $13.3M | $568.4K | $510.2K |
| Mar 2012 | $17.3M | $76.8K | $0 |
| Jun 2012 | $16.7M | $65.6K | $15.5K |
| Sep 2012 | $16.6M | $28.7K | $0 |
| Dec 2012 | $11.3M | $29.4K | $0 |
| Mar 2013 | $12.3M | $28.3K | $0 |
| Jun 2013 | $3.4M | $597.7K | $569.6K |
| Sep 2013 | $3.5M | $168.6K | $129.8K |
| Dec 2013 | $2.3M | $19.9M | $19.7M |
| Mar 2014 | $1.3M | $18.1M | $17.9M |
| Jun 2014 | $1.2M | $18.5M | $18.4M |
| Sep 2014 | $1.3M | $17.4M | $17.2M |
| Dec 2014 | $1.7M | $46.5M | $44.9M |
| Mar 2015 | $1.9M | $113.5M | $111.3M |
| Jun 2015 | $1.9M | $114.7M | $12.6M |
| Sep 2015 | $2.9M | $112.2M | $30.8M |
| Dec 2015 | $1.6M | $105.7M | $33.6M |
| Mar 2016 | $1.8M | $100.8M | $38.9M |
| Jun 2016 | $4.6M | $193.5M | $121.0M |
| Sep 2016 | $3.2M | $182.3M | $92.9M |
| Dec 2016 | $5.0M | $171.9M | $106.7M |
| Mar 2017 | $5.5M | $155.4M | $107.1M |
| Jun 2017 | $8.9M | $138.0M | $114.3M |
| Sep 2017 | $8.5M | $174.0M | $163.4M |
| Dec 2017 | $9.9M | $155.4M | $145.4M |
| Mar 2018 | $14.7M | $307.2M | $297.1M |
| Jun 2018 | $14.2M | $284.8M | $246.0M |
| Sep 2018 | $16.7M | $270.8M | $80.7M |
| Dec 2018 | $14.6M | $480.8M | $82.2M |
| Mar 2019 | $26.6M | $461.5M | $54.1M |
| Jun 2019 | $38.5M | $435.9M | $76.9M |
| Sep 2019 | $40.7M | $395.7M | $38.9M |
| Dec 2019 | $45.7M | $344.7M | $14.0M |
| Mar 2020 | $45.0M | $288.3M | $52.5M |
| Jun 2020 | $59.3M | $817.6M | $160.6M |
| Sep 2020 | $70.5M | $782.3M | $68.3M |
| Dec 2020 | $112.0M | $768.5M | $67.3M |
| Mar 2021 | $103.1M | $750.6M | $132.0M |
| Jun 2021 | $108.4M | $852.8M | $82.8M |
| Sep 2021 | $130.5M | $828.8M | $58.6M |
| Dec 2021 | $155.7M | $777.3M | $78.2M |
| Mar 2022 | $149.3M | $701.3M | $92.4M |
| Jun 2022 | $138.2M | $610.9M | $108.1M |
| Sep 2022 | $152.2M | $545.9M | $118.4M |
| Dec 2022 | $164.3M | $664.0M | $231.7M |
| Mar 2023 | $157.9M | $824.8M | $543.5M |
| Jun 2023 | $178.7M | $757.3M | $230.0M |
| Sep 2023 | $178.3M | $852.3M | $267.7M |
| Dec 2023 | $195.7M | $780.4M | $114.9M |
| Mar 2024 | $189.8M | $869.8M | $134.2M |
| Jun 2024 | $195.8M | $964.3M | $228.7M |
| Sep 2024 | $217.7M | $991.1M | $164.2M |
| Dec 2024 | $200.0M | $910.4M | $115.7M |
| Mar 2025 | $198.9M | $966.7M | $171.7M |
| Jun 2025 | $208.9M | $907.4M | $132.5M |
| Sep 2025 | $202.7M | $904.9M | $158.1M |
| Dec 2025 | $214.6M | $913.2M | $163.1M |
| Mar 2026 | $203.9M | $925.7M | $196.5M |
| Jun 2026 | $179.5M | $915.5M | $110.8M |